...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical psychiatry >Service use and costs of treating schizophrenia with atypical antipsychotics.
【24h】

Service use and costs of treating schizophrenia with atypical antipsychotics.

机译：使用非典型抗精神病药治疗精神分裂症的服务使用和费用。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND: The high acquisition cost of the atypical antipsychotics has prompted their closer clinical and economic evaluation. This study aims to examine the financial implications of using atypical antipsychotics in a defined catchment area sample of patients with schizophrenia. METHOD: Service costs over a 10-month period were compared between groups of patients fulfilling DSM-IV criteria for schizophrenia who were taking different atypical antipsychotic agents. RESULTS: All patients studied were taking clozapine (N = 31). risperidone (N = 19), or olanzapine (N = 41). Clozapine was used in more chronic patients, while risperidone and olanzapine were prescribed in both chronic and recently diagnosed cases. After background group differences were controlled for, patients on risperidone treatment incurred the lowest costs. The monthly costs for the clozapine and olanzapine groups were higher than for risperidone by US
机译：背景：非典型抗精神病药的高昂购置成本促使其进行了更为严格的临床和经济评估。这项研究旨在研究在精神分裂症患者的特定集水区样本中使用非典型抗精神病药的财务意义。方法：比较接受不同非典型抗精神病药的精神分裂症患者符合DSM-IV标准的10个月期间的服务费用。结果：所有研究的患者均服用氯氮平（N = 31）。利培酮（N = 19）或奥氮平（N = 41）。氯氮平用于更长期的患者，而利培酮和奥氮平在慢性和新近诊断的患者中均开处方。在控制了背景组的差异后，接受利培酮治疗的患者费用最低。美国的氯氮平和奥氮平组的每月费用高于利培酮

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号